Systemic and local immunosuppression in glioblastoma and its prognostic significance
Article in Frontiers in Immunology (February 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
Article in Frontiers in Immunology (February 2024)
PARP inhibitor plus radiotherapy reshape the immune suppressive microenvironment and potentiate the efficacy of immune checkpoint inhibitors in tumors with IDH1 mutation
Article in Cancer Letters (January 2024)